Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$10.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 15 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 47 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 234,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 238,973 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 87,220 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 165,289 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 23,809 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 233,252 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 374,985 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 292,179 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,527 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 4,739 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 2,328 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 5,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 159,762 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 277,075 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 20, 2025 | AKRO | Akero Therapeutics, Inc. | GGIFT | 74,538 | — | — | -14.6% | Open the original filing on SEC.gov |
| Nov 12, 2025 | AKRO | Akero Therapeutics, Inc. | GGIFT | 14,739 | — | — | -2.8% | Open the original filing on SEC.gov |
| Oct 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 30,000 | $53.98 | $1.6M | -5.4% | Open the original filing on SEC.gov |
| Oct 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 30,000 | $19.87 | $596.1K | +5.7% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 52,212 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 52,212 | $0.615 | $32.1K | +11.0% | Open the original filing on SEC.gov |
| Sep 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 1,796 | $43.02 | $77.3K | -0.4% | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 1,919 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 13,022 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 158 | $44.62 | $7K | <0.1% | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 7,317 | $44.00 | $321.9K | -1.5% | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 22,525 | $42.99 | $968.4K | -4.5% | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 1,919 | $19.87 | $38.1K | +0.4% | Open the original filing on SEC.gov |
| Sep 10, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 13,022 | $6.36 | $82.9K | +2.6% | Open the original filing on SEC.gov |
| Aug 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 400 | $49.44 | $19.8K | <0.1% | Open the original filing on SEC.gov |
| Aug 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 18,805 | $48.87 | $918.9K | -3.7% | Open the original filing on SEC.gov |
| Aug 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 10,795 | $48.07 | $518.9K | -2.1% | Open the original filing on SEC.gov |
| Jul 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 15,314 | $51.73 | $792.2K | -2.9% | Open the original filing on SEC.gov |
| Jul 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 14,686 | $50.57 | $742.7K | -2.7% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 890 | $23.87 | $21.2K | +0.2% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 6,620 | $54.84 | $363K | -1.2% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 7,837 | $53.99 | $423.2K | -1.4% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 15,158 | $54.35 | $823.9K | -2.6% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 14,842 | $53.76 | $797.9K | -2.5% | Open the original filing on SEC.gov |
| May 14, 2025 | VERA | Vera Therapeutics, Inc. | AGRANT◆ | 14,000 | — | — | — | Open the original filing on SEC.gov |
| May 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 22,800 | $41.63 | $949.3K | -3.7% | Open the original filing on SEC.gov |
| May 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 7,200 | $41.00 | $295.2K | -1.1% | Open the original filing on SEC.gov |
| Apr 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 30,000 | $35.23 | $1.1M | -4.6% | Open the original filing on SEC.gov |